Intravacc has developed several proprietary platforms to streamline the development of new vaccines. These platforms are the culmination of decades of successful vaccine innovation, and embody our knowledge and procedural blueprints for fast, efficient, and scalable vaccine design and development.
Our OMV-Vacc technology is an innovative platform for versatile, safe, and effective vaccine production. Explore its suitability for infectious diseases, AMR, and oncology.
Our Cell-Vacc technology is a globally trusted platform using a Vero GMP cell line for reliable, large-scale production of viral vaccines for oncology and infectious diseases.
Explore Con-Vacc technology, built on 20 years of proven excellence in designing cost-effective conjugate vaccines for infectious diseases and therapeutic applications.
Leverage E.co-Vacc technology, a global leader in fast, cost-effective, flexible, and reliable bacterial expression for recombinant proteins in vaccine manufacturing.